Health news round-up: NICE approvals, surveillance data and GLP-1 warnings A weekly summary of important developments in pharmacy and health news that you may have missed.…
Managing neuropathic pain in bipolar disorder An overview of the clinical considerations for managing comorbid bipolar disorder and neuropathic pain.…
Is a cure for epidermolysis bullosa on the horizon? New trials to repurpose drugs for the rare genetic skin condition epidermolysis bullosa are offering families a level of hope not seen before, raising the question of whether a cure may finally be in sight.…
Almost half of weight-loss drug users modify doses, finds survey Results from a survey conducted by LloydsPharmacy Online Doctor also showed that more than one-quarter of respondents said they had knowingly bought weight-loss injections from unlicensed sellers.…
Coroner highlights lack of head injury warnings for anticoagulant A patient prescribed apixaban, who died following a fall, was unaware of the risks that the anticoagulant presented in the event of head trauma.…
NHS England recommends extension of drug to treat non-metastatic prostate cancer A new NHS clinical commissioning policy has given permission for abiraterone acetate to be prescribed off-label to men with high-risk, hormone sensitive, non-metastatic cancer.…
NICE recommends treatment that could help 30,000 people with COPD Guidance says dupilumab can be offered as an add-on maintenance treatment for adults with uncontrolled COPD.…
Weight-loss drugs among £45m of illegally traded medicines seized in 2025 Medicines and Healthcare products Regulatory Agency figures show that more than 5,000 glucagon-like peptide-1 products were seized in 2025.…
Two-prescriber sign-off no longer required for isotretinoin The Medicines and Healthcare products Regulatory Agency said that scrapping the two-prescriber requirement will address delays in access to acne treatment for patients aged under 18 years old.…
Drug consumption room pilot records more than 1,000 injecting episodes in a month According to latest service data on The Thistle, a drug consumption facility in Glasgow, 560 people used the site's services more than 10,000 times in 2025.…
